Leadership Overview
Velocity Clinical Research has 6 executives leading key functions including strategy, financial planning, human capital, legal compliance, clinical operations, and medical oversight.
Committed to accelerating medical breakthroughs, Velocity Clinical Research delivers integrated site capabilities to biopharmaceutical partners while maintaining a rigorous focus on patient recruitment and trial excellence.
Committed to accelerating medical breakthroughs, Velocity Clinical Research delivers integrated site capabilities to biopharmaceutical partners while maintaining a rigorous focus on patient recruitment and trial excellence.
Leadership Roles at Velocity Clinical Research
George Carey - Chief Executive Officer
George Carey, the Chief Executive Officer at Velocity Clinical Research, directs the overarching corporate strategy and long-term vision for the organization. By aligning clinical trial site capabilities with the evolving needs of biopharmaceutical customers, the Chief Executive Officer ensures consistent growth across North American markets. George Carey maintains direct oversight of executive leadership initiatives, fostering a culture of operational excellence and scientific integrity. This leadership role involves constant engagement with the Board to refine business models and expand the footprint of integrated research sites. Through the optimization of patient recruitment workflows, the Chief Executive Officer drives significant value for contract research organization partners. By prioritizing high-quality data collection and site performance, Carey secures the company's position as a premier partner in the global clinical research landscape, ultimately advancing the development of life-saving medical treatments through strategic resource allocation and organizational focus.
Mike Zaranek - Chief Financial Officer
Mike Zaranek, the Chief Financial Officer at Velocity Clinical Research, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing financial reporting, budgeting, and long-term investment planning, the Chief Financial Officer ensures the company maintains the necessary resources to scale clinical trial site operations effectively. Mike Zaranek directs the financial analysis of potential site acquisitions and infrastructure expansions, providing the data-driven insights required for sustainable growth. This leadership role involves close collaboration with the executive team to monitor revenue streams from biopharmaceutical partnerships and optimize cost structures across all research facilities. By implementing robust financial controls and risk management frameworks, Zaranek protects the company's assets while supporting aggressive market expansion. Through meticulous oversight of capital expenditures and cash flow management, the Chief Financial Officer sustains the financial stability required to support complex, multi-site clinical research programs on a national scale.
Robert Buynak - Physician and President
Robert Buynak, the Physician and President at Velocity Clinical Research, provides the medical leadership and clinical oversight necessary for high-quality trial execution. Overseeing the medical standards and scientific integrity of all research protocols, the Physician and President ensures that every site adheres to the highest clinical benchmarks. Robert Buynak directs the medical staff and principal investigators, fostering a culture of scientific excellence and patient safety. This leadership role involves collaborating with biopharmaceutical partners to ensure that trial designs are feasible and that patient populations are accurately identified. By bridging the gap between clinical research and medical practice, Buynak enhances the company's ability to deliver reliable data for drug development. Through the strategic oversight of medical quality assurance and protocol compliance, the Physician and President supports the company's reputation as a trusted partner in the clinical research industry, ensuring that all trials are conducted with precision and ethical rigor.
Kimberly Ballard - Chief People Officer
Kimberly Ballard, the Chief People Officer at Velocity Clinical Research, architects the human capital strategy required to support a vast network of clinical research professionals. Overseeing talent acquisition, employee development, and organizational culture, the Chief People Officer ensures the company attracts and retains the specialized expertise necessary for high-stakes clinical trials. Kimberly Ballard directs initiatives focused on workforce engagement and performance management, aligning individual contributions with the broader mission of accelerating medical research. This leadership role involves designing comprehensive training programs that maintain compliance and operational standards across all research sites. By fostering an inclusive and high-performance environment, Ballard drives organizational agility and employee retention. Through the implementation of modern HR technologies and strategic workforce planning, the Chief People Officer supports the company's ability to scale operations rapidly, ensuring that every site remains staffed with top-tier talent capable of delivering exceptional results for biopharmaceutical clients.
Brandi Lang - Chief Legal Officer
Brandi Lang, the Chief Legal Officer at Velocity Clinical Research, manages all legal affairs, regulatory compliance, and corporate governance matters. Overseeing the complex contractual landscape between the company, biopharmaceutical sponsors, and clinical trial sites, the Chief Legal Officer ensures adherence to stringent industry regulations and ethical standards. Brandi Lang directs the legal strategy for site acquisitions, intellectual property protection, and risk mitigation across all operational regions. This leadership role involves providing counsel to the executive team on legislative changes and industry-specific legal requirements that impact clinical trial execution. By establishing robust compliance frameworks, Lang safeguards the company's reputation and operational continuity. Through the proactive management of litigation risks and the negotiation of high-value partnership agreements, the Chief Legal Officer supports the company's strategic objectives. This focus on legal excellence ensures that all research activities remain compliant with federal and international standards, facilitating seamless collaboration with global research partners.
Nicholas Spittal - Chief Operations Officer
Nicholas Spittal, the Chief Operations Officer at Velocity Clinical Research, directs the daily execution of clinical trial site activities and operational workflows. Overseeing the performance of the integrated site network, the Chief Operations Officer ensures that patient recruitment, data integrity, and trial timelines meet the rigorous demands of biopharmaceutical customers. Nicholas Spittal architects scalable operational processes that allow the company to manage multiple complex studies simultaneously across diverse geographic locations. This leadership role involves coordinating with site directors and clinical staff to optimize resource utilization and maintain high standards of patient care. By implementing standardized operating procedures and performance metrics, Spittal drives efficiency and consistency throughout the organization. Through the continuous monitoring of site-level metrics and operational bottlenecks, the Chief Operations Officer ensures that all research facilities operate at peak capacity, ultimately supporting the company's mission to accelerate the delivery of new medical therapies to the market.
Explore Leadership Teams in Business Services
About the South African Medical Research Council (SAMRC): The South African Medical Research Council (SAMRC) was established in 1969 with a mandate to improve the health of the country's population, through research, development and technology transfer, so that people can enjoy a better quality of life. The scope of the organisation's research projects includes tuberculosis, HIV/AIDS, cardiovascular and non-communicable diseases, gender and health, and alcohol and other drug abuse. With a strategic objective to help strengthen the health systems of the country - in line with that of the Department of Health, the SAMRC constantly identifies the main causes of death in South Africa.
Company Leadership NN
MT
Danaher Corporation operates across the biotechnology, life sciences, and diagnostics sectors, delivering integrated solutions that enable the development and manufacture of therapeutic products globally. The company designs and manufactures specialized equipment, consumables, and services that address complex challenges in drug development, laboratory analysis, and clinical diagnostics. Within biotechnology, Danaher provides comprehensive bioprocess technologies and manufacturing support systems that streamline the creation of therapeutics. This includes cell culture media development, chromatography resins, filtration technologies, and single-use hardware alongside design and installation services for complete manufacturing suites. The company also offers laboratory-scale protein purification tools, analytical instruments, and healthcare filtration solutions that serve manufacturers and research institutions. The life sciences division encompasses advanced analytical instrumentation including mass spectrometers, flow cytometry systems, genomics platforms, and microscopy solutions. Danaher supplies critical consumables such as antibodies, reagents, and protein products, along with industrial filtration systems and genomic medicine offerings including custom nucleic acid products and plasmid DNA. These capabilities operate under several established brands that serve research and industrial applications.
Company Leadership
EL
Mistras Group, Inc. provides technology-enabled asset protection solutions in the United States, other Americas, Europe, and the Asia-Pacific. The company offers non-destructive testing services; inline inspection for pipelines; and plant condition management software. It also provides maintenance and light mechanical services, such as corrosion removal, mitigation and prevention, insulation installation and removal, electrical, heat tracing, industrial cleaning, pipefitting, and welding; engineering consulting services primarily for process equipment, technologies, and facilities; and utilizes scaffolding and rope access to access at-height and confined assets. In addition, the company offers certified divers for subsea inspection and maintenance; unmanned aerial, land-based, and subsea systems for inspection applications; online condition-monitoring solutions; quality assurance and quality control solutions for new and existing metal and alloy components, materials, and composites. Further, it builds monitoring systems, as well as provides inspection, maintenance, monitoring and data services; and Web-based solutions. Additionally, the company designs, manufactures, and sells acoustic emission sensors, instruments, and turnkey systems for monitoring and testing materials, pressure components, processes, and structures; and ultrasonic testing equipment. It serves oil and gas, aerospace and defense, fossil and nuclear power, power generation and transmission, civil infrastructure, manufacturing, industrial, public infrastructure, petrochemical, transportation, and other process industries, as well as infrastructure, research, and engineering industries. Mistras Group, Inc. was founded in 1978 and is headquartered in Princeton Junction, New Jersey.
Company Leadership NS
RF
Founded in 2002 and headquartered in Piscataway, New Jersey, Genscript is the worlds leading biotech company providing life sciences services and products. The company has four platforms including leading life-science services and products platform to provide one-stop solutions to global research communities, a biologics contract development and manufacturing organization (the "CDMO") platform, an industrial synthetic products platform, and an integrated global cell therapy platform.
Company Leadership PL
SW
Frequently Asked Questions Regarding Velocity Clinical Research Top Executives and Leadership Team
Unlock more people and company data
